Oral cholera vaccine for traveler's diarrhea prophylaxis

Canadian Family Physician

Volumn 60, Issue 5, 2014, Pages 451-

  Nickonchuk, Tony ^a   Lindblad, Adrienne J ^b   Kolber, Michael R ^c  

^a Alberta College of Family Physicians ^*

^b Department of Family Medicine University of Alberta ^*  (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; BISMUTH SALICYLATE; CHOLERA VACCINE; PLACEBO;

ARTICLE; DEVELOPING COUNTRY; ESCHERICHIA COLI INFECTION; FRUIT JUICE; HEALTH CARE PLANNING; HEPATITIS A; HUMAN; INFECTION; LOWEST INCOME GROUP; MORBIDITY; PRACTICE GUIDELINE; PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW (TOPIC); TRAVELLER DIARRHEA; VACCINATION; CHOLERA; COMPLICATION; DIARRHEA; TRAVEL; TREATMENT OUTCOME; VIROLOGY;

CHOLERA; CHOLERA VACCINES; DIARRHEA; HUMANS; TRAVEL; TREATMENT OUTCOME;

EID: 84901370085     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Ahmed T, Bhuiyan TR, Zaman K, Sinclair D, Qadri F. Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea. Cochrane Database Syst Rev 2013;(7):CD009029.
2. Scerpella EG, Sanchez JL, Mathewson JJ III, Torres-Cordero JV, Sadoff JC, Svennerholm AM, et al. Safety, immunogenicity, and protective efficacy of the whole-cell/recombinant B subunit (WC/rBS) oral cholera vaccine against travelers' diarrhea. J Travel Med 1995;2(1):22-7.
3. Wiedermann G, Kollaritsch H, Kundi M, Svennerholm AM, Bjare U. Double-blind, randomized, placebo controlled pilot study evaluating efficacy and reactogenicity of an oral ETEC B-subunit-inactivated whole cell vaccine against travelers' diarrhea (preliminary report). J Travel Med 2000;7(1):27-9. (Pubitemid 30126847)
4. Public Health Agency of Canada. Statement on new oral cholera and travellers' diarrhea vaccination. Canada Communicable Disease Report 2005;31:1-12. Available from: www.phac-aspc.gc.ca/publicat/ccdr-rmtc/05vol31/ asc-dcc-7/index-eng.php. Accessed 2013 Nov 8.
5. Hill DR, Ericsson CD, Pearson RD, Keystone JS, Freedman DO, Kozarsky PE, et al. The practice of travel medicine: guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006;43(12):1499-539. Epub 2006 Nov 8.
6. Adachi JA, Jiang ZD, Mathewson JJ, Verenkar MP, Thompson S, Martinez-Sandoval F, et al. Enteroaggregative Escherichia coli as a major etiologic agent in traveler's diarrhea in 3 regions of the world. Clin Infect Dis 2001;32(12):1706-9. Epub 2001 May 21.
7. Steffen R, Acar J, Walker E, Zuckerman J. Cholera: assessing the risk to travellers and identifying methods of protection. Travel Med Infect Dis 2003;1(2):80-8. (Pubitemid 40432881)
8. Hill DR, Ford L, Lalloo DG. Oral cholera vaccines: use in clinical practice. Lancet Infect Dis 2006;6(6):361-73. (Pubitemid 43737274)
9. Dukoral. Oral, inactivated travellers' diarrhea and cholera vaccine [product monograph]. Toronto, ON: Crucell Vaccines Canada; 2012. p. 5. Available from: www.janssen.ca/subcategory-docdownload?id=1586. Accessed 2013 Dec 8.
10. De Bruyn G, Hahn S, Borwick A. Antibiotic treatment for travellers' diarrhoea. Cochrane Database Syst Rev 2000;(3):CD002242.
11. Al-Abri SS, Beeching NJ, Nye FJ. Traveller's diarrhoea. Lancet Infect Dis 2005;5(6):349-60. (Pubitemid 40779256)
12. Blondel-Hill E, Fryters S. Bugs and drugs. 5th ed. Edmonton, AB: Alberta Health Services; 2012.
13. Ericsson CD, DuPont HL, Okhuysen PC, Jiang ZD, DuPont MW. Loperamide plus azithromycin more effectively treats travelers' diarrhea in Mexico than azithromycin alone. J Travel Med 2007;14(5):312-9. (Pubitemid 47460252)